KLH in News

News of companies, products and development related to KLH. Full information is provided by link to third-party sites.

(in order by date)

Tuesday
Apr032012

Stellar Biotechnologies Launches Stellar KLH™ ELISA Test Kits

SOURCE: Stellar Biotechnologies, Inc.

Click to read more ...

Thursday
Jan192012

Biovest Prepares for EU Regulatory Meetings; SME Status Granted Providing European Regulatory Benefits for BiovaxID Personalized Lymphoma Vaccine

SOURCE: Biovest International, Inc.

Click to read more ...

Thursday
Jan052012

Major milestone achieved: the Phase IIa clinical trial in rheumatoid arthritis meets its endpoint

SOURCE: Neovacs

Click to read more ...

Wednesday
Jan042012

Celldex Initiates a Phase 2 Study of Rindopepimut in Patients with Recurrent Glioblastoma including Avastin® Naive and Refractory Populations

SOURCE: Celldex Therapeutics, Inc.

Click to read more ...

Monday
Dec122011

Vaccine Isotype Seems to Affect Clinical Outcome in Blood Cancer Trials

SOURCE: Genetic Engineering News

Click to read more ...

Tuesday
Dec062011

Stellar Biotechnologies Announces Significant Expansion of Keyhole Limpet Hatchery & Sera Production Capability

SOURCE: Stellar Biotechnologies, Inc.

Click to read more ...

Thursday
Dec012011

Celldex Initiates ACT IV, a Pivotal International Phase 3 Trial of Rindopepimut in Patients with Glioblastoma

SOURCE: Celldex Therapeutics, Inc.

Click to read more ...

Tuesday
Nov222011

Biovest Defines Role of BiovaxID® Personalized Cancer Vaccine in Journal of Clinical Oncology

SOURCE: Biovest International

Click to read more ...

Monday
Nov212011

Celldex Therapeutics Reports Positive Mature Survival Data from Rindopepimut Phase 2 Brain Cancer Study at SNO 2011

SOURCE: Celldex Therapeutics, Inc.

Click to read more ...

Tuesday
Nov082011

Does Clinical Success Mean Commercial Success for Cancer Vaccines?

SOURCE: Genetic Engineering News

Click to read more ...